AVITA Medical (RCEL) Shares Outstanding (2018 - 2025)

AVITA Medical (RCEL) has 8 years of Shares Outstanding data on file, last reported at $30.6 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 16.0% year-over-year to $30.6 million; the trailing twelve-month figure through Dec 2025 stood at $30.6 million (up 16.0% YoY), and the FY2025 full-year result was $30.6 million, up 16.0% from the prior year.
• Shares Outstanding for Q4 2025 stood at $30.6 million, roughly flat from $30.5 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $30.6 million in Q4 2025 and bottomed at $24.8 million in Q1 2021.
• The 5-year median for Shares Outstanding is $25.5 million (2023), against an average of $26.0 million.
• The widest annual swing landed in 2021, when Shares Outstanding gained 16.5%; it then advanced 0.42% in 2022.
• A 5-year view of Shares Outstanding shows it stood at $24.9 million in 2021, then gained by 1.13% to $25.2 million in 2022, then increased by 1.88% to $25.7 million in 2023, then grew by 2.62% to $26.4 million in 2024, then rose by 16.0% to $30.6 million in 2025.
• The last three Shares Outstanding figures came in at $30.6 million (Q4 2025), $30.5 million (Q3 2025), and $26.6 million (Q2 2025), per Business Quant data.

Peer Comparison